Allakos Completes Patient Enrollment in Phase 3 Eosinophilic Gastritis and/or Eosinophilic Duodenitis and Phase 2/3 Eosinophilic Esophagitis Clinical Trials of Lirentelimab (AK002)

NEXT STORY
Berkshire Grey to Present at the UBS Global Industrials and Transportation Virtual Conference on June 8, 2021
PREV STORY
Salarius Pharmaceuticals Presents New Research Data Demonstrating Seclidemstat’s Safety, Dosing, and Drug Activity at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rafael Pharmaceuticals Announces Positive Preplanned Interim Futility Analysis of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

author_avatar
NASDAQ Market News

Global proteomics market is expected to undergo a healthy growth during the forecast period and is projected to reach USD66.59 billion by 2026

author_avatar
NASDAQ Market News

Insmed Reports Third Quarter 2017 Financial Results and Provides Business Update

During the third quarter, the Company announced positive top-line results from its Phase 3 ...

author_avatar
NASDAQ Market News